Nicholas Alexander Vitanza MD
Pediatric Neuro-Oncology
Pediatric Neuro-Oncologist and Translational Scientist at Seattle Children's
Join to View Full Profile
4800 Sand Point Way NE# MB8Seattle, WA 98105
Phone+1 845-559-3679
Dr. Vitanza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Neuro-Oncology, 2014 - 2016
NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Stony Brook Medicine/University HospitalResidency, Pediatrics, 2008 - 2011
American University of the Caribbean School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2014 - Present
WA State Medical License 2016 - 2027
ID State Medical License 2021 - 2026
AK State Medical License 2021 - 2022
NY State Medical License 2011 - 2019
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Young Investigator Travel Stipend Award American Society of Pediatric Hematology/Oncology, 2014
- Research Training Award for Fellows American Society of Hematology, 2013
Clinical Trials
- ONC201 in Pediatric H3 K27M Gliomas Start of enrollment: 2018 Jan 25
- HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors Start of enrollment: 2018 Jul 26
Publications & Presentations
PubMed
- Children with medulloblastoma treated with modified ACNS0821 temozolomide, irinotecan, and bevacizumab: The Seattle Children's Hospital experience.Rebecca Ronsley, Miranda C Bradford, Erin E Crotty, Nicholas A Vitanza, Daniel V Runco
Neuro-Oncology Practice. 2025-06-01 - Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models.Jessica B Foster, Peter J Madsen, Kyra Harvey, Crystal Griffin, Allison Stern
Neuro-Oncology. 2025-05-24 - Evolving CAR T-Cell Therapy to Overcome the Barriers in Treating Pediatric Central Nervous System Tumors.Andrea Timpanaro, Edward Z Song, Nour Amwas, Chu-Hsuan Chiu, Rebecca Ronsley
Cancer Discovery. 2025-05-02
Press Mentions
Experimental Treatment Borrowed from Blood Cancer Shows Promise for Pediatric Brain TumorsMarch 19th, 2025- Novel Approaches to Malignant Brain Tumor Treatment Aim to Overcome Familiar ChallengesJanuary 27th, 2022
- AeroPress Grants Cancer Research Award to Dr. Nicholas VitanzaMarch 24th, 2021
- Join now to see all
Grant Support
- B7-H3 CAR T cells following initial radiation for children and young adults with diffuse intrinsic pontine gliomaSEATTLE CHILDREN'S HOSPITAL2025–2030
- Research Training Award for FellowsAmerican Society of Hematology2013–2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
